This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krivan, H C
Right arrow Articles by Wilkins, T D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krivan, H C
Right arrow Articles by Wilkins, T D

 Previous Article  |  Next Article 

Infect Immun. 1986 September; 53(3): 573-581

Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

H C Krivan, G F Clark, D F Smith and T D Wilkins

ABSTRACT

This study was undertaken to determine whether a binding site for Clostridium difficile enterotoxin (toxin A) exists in the brush border membranes (BBMs) of the hamster, an animal known to be extremely sensitive to the action of the toxin. Toxin A was the only antigen adsorbed by the BBMs from the culture filtrate of C. difficile. The finding that binding activity could not be destroyed by heat indicated that a carbohydrate moiety might be involved. We therefore examined erythrocytes from various animal species for binding activity since erythrocytes provide a variety of carbohydrate sequences on their cell surfaces. Only rabbit erythrocytes bound the toxin, and the cells agglutinated. A binding assay based on an enzyme-linked immunosorbent assay method for quantifying C. difficile toxin A was used to compare binding of the toxin to hamster BBMs, rabbit erythrocytes, and BBMs from rats, which are less susceptible to the action of C. difficile toxin A than hamsters. Results of this comparison indicated the following order of toxin-binding frequency: rabbit erythrocytes greater than hamster BBMs greater than rat BBMs. Binding of toxin A to hamster BBMs at 37 degrees C was comparable to what has been observed with cholera toxin, but binding was enhanced at 4 degrees C. A similar binding phenomenon was observed with rabbit erythrocytes. Examination of the cell surfaces of hamster BBMs and rabbit erythrocytes with lectins and specific glycosidases revealed a high concentration of terminal alpha-linked galactose. Treatment of both membrane types with alpha-galactosidase destroyed the binding activity. The glycoprotein, calf thyroglobulin, also bound the toxin and inhibited toxin binding to cells. Toxin A did not bind to human erythrocytes from blood group A, B, or O donors. However, after fucosidase treatment of human erythrocytes, only blood group B erythrocytes, which possess the blood group B structure Gal alpha 1-3[Fuc alpha 1-2]Gal beta 1-4GlcNAc-R, bound the toxin. This indicated that toxin A was likely binding to Gal alpha 1-3Gal beta 1-4GlcNAc, a carbohydrate sequence also found on calf thyroglobulin and rabbit erythrocytes. All of the results indicate that hamster BBMs contain a carbohydrate-binding site for toxin A that has at least a Gal alpha 1-3Gal beta 1-4GlcNAc nonreducing terminal sequence.

Infect Immun. 1986 September; 53(3): 573-581




This article has been cited by other articles:

  • He, X., Sun, X., Wang, J., Wang, X., Zhang, Q., Tzipori, S., Feng, H. (2009). Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium difficile Toxin A. Infect. Immun. 77: 2294-2303 [Abstract] [Full Text]  
  • Dingle, T., Wee, S., Mulvey, G. L, Greco, A., Kitova, E. N, Sun, J., Lin, S., Klassen, J. S, Palcic, M. M, Ng, K. K S, Armstrong, G. D (2008). Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 18: 698-706 [Abstract] [Full Text]  
  • Na, X., Kim, H., Moyer, M. P., Pothoulakis, C., LaMont, J. T. (2008). gp96 Is a Human Colonocyte Plasma Membrane Binding Protein for Clostridium difficile Toxin A. Infect. Immun. 76: 2862-2871 [Abstract] [Full Text]  
  • Giesemann, T., Egerer, M., Jank, T., Aktories, K. (2008). Processing of Clostridium difficile toxins. J Med Microbiol 57: 690-696 [Abstract] [Full Text]  
  • Yeh, C.-Y., Lin, C.-N., Chang, C.-F., Lin, C.-H., Lien, H.-T., Chen, J.-Y., Chia, J.-S. (2008). C-Terminal Repeats of Clostridium difficile Toxin A Induce Production of Chemokine and Adhesion Molecules in Endothelial Cells and Promote Migration of Leukocytes. Infect. Immun. 76: 1170-1178 [Abstract] [Full Text]  
  • Keel, M. K., Songer, J. G. (2007). The Distribution and Density of Clostridium difficile Toxin Receptors on the Intestinal Mucosa of Neonatal Pigs. Vet Pathol 44: 814-822 [Abstract] [Full Text]  
  • Youderian, P., Hartzell, P. L. (2007). Triple Mutants Uncover Three New Genes Required for Social Motility in Myxococcus xanthus. Genetics 177: 557-566 [Abstract] [Full Text]  
  • Ghose, C., Kalsy, A., Sheikh, A., Rollenhagen, J., John, M., Young, J., Rollins, S. M., Qadri, F., Calderwood, S. B., Kelly, C. P., Ryan, E. T. (2007). Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice. Infect. Immun. 75: 2826-2832 [Abstract] [Full Text]  
  • Jank, T., Giesemann, T., Aktories, K. (2007). Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17: 15R-22R [Abstract] [Full Text]  
  • Keel, M. K., Songer, J. G. (2006). The Comparative Pathology of Clostridium difficile-associated Disease. Vet Pathol 43: 225-240 [Abstract] [Full Text]  
  • Giesemann, T., Jank, T., Gerhard, R., Maier, E., Just, I., Benz, R., Aktories, K. (2006). Cholesterol-dependent Pore Formation of Clostridium difficile Toxin A. J. Biol. Chem. 281: 10808-10815 [Abstract] [Full Text]  
  • Ho, J. G. S., Greco, A., Rupnik, M., Ng, K. K.-S. (2005). Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. USA 102: 18373-18378 [Abstract] [Full Text]  
  • Voth, D. E., Ballard, J. D. (2005). Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clin. Microbiol. Rev. 18: 247-263 [Abstract] [Full Text]  
  • Solomon, K., Webb, J., Ali, N., Robins, R. A., Mahida, Y. R. (2005). Monocytes Are Highly Sensitive to Clostridium difficile Toxin A-Induced Apoptotic and Nonapoptotic Cell Death. Infect. Immun. 73: 1625-1634 [Abstract] [Full Text]  
  • Castagliuolo, I., Sardina, M., Brun, P., DeRos, C., Mastrotto, C., Lovato, L., Palu, G. (2004). Clostridium difficile Toxin A Carboxyl-Terminus Peptide Lacking ADP-Ribosyltransferase Activity Acts as a Mucosal Adjuvant. Infect. Immun. 72: 2827-2836 [Abstract] [Full Text]  
  • Barbut, F., Lalande, V., Burghoffer, B., Thien, H. V., Grimprel, E., Petit, J.-C. (2002). Prevalence and Genetic Characterization of Toxin A Variant Strains of Clostridium difficile among Adults and Children with Diarrhea in France. J. Clin. Microbiol. 40: 2079-2083 [Abstract] [Full Text]  
  • Pothoulakis, C., Lamont, J. T. (2001). Microbes and Microbial Toxins: Paradigms for Microbial- Mucosal Interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G178-G183 [Abstract] [Full Text]  
  • Genth, H., Selzer, J., Busch, C., Dumbach, J., Hofmann, F., Aktories, K., Just, I. (2000). New Method To Generate Enzymatically Deficient Clostridium difficile Toxin B as an Antigen for Immunization. Infect. Immun. 68: 1094-1101 [Abstract] [Full Text]  
  • Ward, S. J., Douce, G., Dougan, G., Wren, B. W. (1999). Local and Systemic Neutralizing Antibody Responses Induced by Intranasal Immunization with the Nontoxic Binding Domain of Toxin A from Clostridium difficile. Infect. Immun. 67: 5124-5132 [Abstract] [Full Text]  
  • Ward, S. J., Douce, G., Figueiredo, D., Dougan, G., Wren, B. W. (1999). Immunogenicity of a Salmonella typhimurium aroA aroD Vaccine Expressing a Nontoxic Domain of Clostridium difficile Toxin A. Infect. Immun. 67: 2145-2152 [Abstract] [Full Text]  
  • Giannasca, P. J., Zhang, Z.-x., Lei, W.-d., Boden, J. A., Giel, M. A., Monath, T. P., Thomas, W. D. Jr. (1999). Serum Antitoxin Antibodies Mediate Systemic and Mucosal Protection from Clostridium difficile Disease in Hamsters. Infect. Immun. 67: 527-538 [Abstract] [Full Text]  
  • Minet, A., Rubin, B., Tucker, R., Baumgartner, S, Chiquet-Ehrismann, R (1999). Teneurin-1, a vertebrate homologue of the Drosophila pair-rule gene ten-m, is a neuronal protein with a novel type of heparin-binding domain. J. Cell Sci. 112: 2019-2032 [Abstract]  
  • Kink, J. A., Williams, J. A. (1998). Antibodies to Recombinant Clostridium difficile Toxins A and B Are an Effective Treatment and Prevent Relapse of C. difficile-Associated Disease in a Hamster Model of Infection. Infect. Immun. 66: 2018-2025 [Abstract] [Full Text]  
  • Lyerly, D., Neville, L., Evans, D., Fill, J, Allen, S, Greene, W, Sautter, R, Hnatuck, P, Torpey, D., Schwalbe, R (1998). Multicenter evaluation of the Clostridium difficile TOX A/B TEST [In Process Citation]. J. Clin. Microbiol. 36: 184-190 [Abstract] [Full Text]  
  • Johansson, E, Jennische, E, Lange, S, Lonnroth, I (1997). Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut 41: 642-645 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»